Acorda Therapeutics, Inc.
(NASDAQ : ACOR)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
1.36%198.321.3%$525.50m
GILDGilead Sciences, Inc.
1.38%66.870.9%$355.36m
ALXNAlexion Pharmaceuticals, Inc.
0.98%106.712.0%$331.00m
ILMNIllumina, Inc.
0.68%307.273.5%$318.06m
BIIBBiogen Inc.
2.56%241.651.3%$313.89m
CELGCelgene Corporation
0.58%99.521.3%$296.26m
VRTXVertex Pharmaceuticals Incorporated
1.51%178.801.9%$177.39m
AAgilent Technologies, Inc.
0.78%78.681.6%$177.23m
REGNRegeneron Pharmaceuticals, Inc.
3.15%295.152.6%$171.61m
SRPTSarepta Therapeutics, Inc.
-2.28%83.4114.6%$141.92m
EXASExact Sciences Corporation
-0.05%103.3524.1%$138.68m
ACADACADIA Pharmaceuticals Inc.
-2.18%40.7713.9%$122.70m
INCYIncyte Corporation
2.30%79.922.5%$87.16m
ALDRAlder Biopharmaceuticals, Inc.
-0.05%18.6510.2%$76.37m
BMRNBioMarin Pharmaceutical Inc.
0.15%76.114.3%$75.73m

Company Profile

Acorda Therapeutics, Inc. engages in the development of therapies that restore function and improve the lives of people with neurological disorders. Its two main products are Ampyra and Zanaflex Capsules. The Ampyra is an oral drug, which treats to improve walking in patients with multiple sclerosis and Zanaflex Capsules, which is a short acting drug for the management of spasticity, a symptom of many central nervous system disorders, including multiple sclerosis and spinal cord injury. The company was founded by Ronald Cohen in 1995 and is headquartered in Ardsley, NY.